To analyze the curative effect of Jugular foramen tumors explore the value of multidisciplinary teams and multiple techniques in surgical management of jugular foramen tumors.

Nineteen patients with jugular foramen tumors accepted surgery from January 2011 to July 2020 in neurosurgery department of the First Affiliated Hospital of Chongqing Medical University. According to the classifications of Samii, they were divided into A type 4 cases, B type 5 cases, C type 0 and D type 7 cases. Fourteen patients underwent micro neurosurgery, another 2 and 3 patients accepted microscopic combined with endoscopic surgery respectively. The surgical approaches included infraoccipital retrosigmoid approach in 5 cases, basic far lateral approach in 7 cases, far lateral transcondylar supracondylar approach in 4 cases, fisch A infratemporal fossa approach in 1 case, and far lateral retrolabyrinthine approach in 2 cases. All patients were treated with adjuvant radiotherapy according to the pathological result and extent of residual tumor. The degree of tumor resection, tumor recurrence, surgical associated complications and preservation of cranial nerve function were analyzed.

The tumor resection rate of subtotal resection and above was 84.2%. One patient was lost to follow-up, and one of the 18 follow-up patients had tumor recurrence one year after operation, and they were operated again in other hospitals. In the remaining follow-up patients, there was no tumor recurrence in the last follow-up period, and the recurrence rate was 5.6%; there was no operation-related death in all patients during the last follow-up period, and 2 patients had occipital subcutaneous effusion (10.5%). Surgical related neurological dysfunction was the most common in Ⅸ-Ⅹ cranial nerve (52.6%, 10/19), followed by Ⅶ cranial nerve (47.4%, 9/19), Ⅷ cranial nerve (36.8%, 7/19) and Ⅻ cranial nerve (10.5%, 2/19). Surgical related temporary neurological dysfunction: 77.8% (7/9) of Ⅶ cranial nerve, 50.0% (3/6) of Ⅷ cranial nerve, 33.3% (3/9) of Ⅸ-Ⅹ cranial nerve and 0 (0/2) of Ⅻ cranial nerve. During the last follow-up period, the rates of preservation and improvement of cranial nerve function in Ⅶ, Ⅷ, Ⅸ-Ⅹ, Ⅺ and Ⅻ were 88.2% (15/17), 82.4% (14/17), 64.7% (11/17), 100% (17/17) and 88.2% (15/17), respectively.

The preservation and improvement of cranial nerves function should be prior goal of surgery. Multidisciplinary teams and multiple techniques have great value on individual surgical treatment of jugular foramen tumors. Adjuvant radiotherapy could be applied to control the recurrence of residual tumor after surgery.